Gaudium IVF Completes Regulatory Publication of Q3 FY26 Financial Results

Gaudium IVF & Women Health Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, following Board approval on March 18, 2026. The healthcare company, specializing in IVF and women's health services, demonstrated mixed operational performance with EBITDA growth offset by margin compression, while consolidated results showed significant year-over-year improvements.

Regulatory Compliance and Newspaper Publication

The Board of Directors meeting commenced at 4:15 p.m. IST and concluded at 6:05 p.m. IST on March 18, 2026. The results were prepared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and subject to limited review by S K G N & Associates LLP, the company's statutory auditors.

Pursuant to Regulation 30 and 47 of SEBI Listing Regulations, the company completed newspaper publication of its approved financial results on March 19, 2026. The newspaper advertisements were published in Financial Express and Jansatta, with the publication also hosted on the company's website at www.gaudiumivfcentre.com . The trading window for designated persons remains closed until March 20, 2026, as per insider trading regulations.

EBITDA Performance Shows Mixed Trends

The company's Q3 FY26 EBITDA performance reflected mixed operational trends with absolute growth accompanied by margin pressure. EBITDA increased to ₹66.00 crores compared to ₹57.00 crores in the corresponding quarter of the previous year, representing a year-over-year improvement in absolute terms.

Metric: Q3 FY26 Q3 FY25 Change (%) EBITDA: ₹66.00 crores ₹57.00 crores +15.79% EBITDA Margin: 26.72% 39.22% -12.50 percentage points

The EBITDA margin compression from 39.22% to 26.72% indicates operational efficiency challenges despite the absolute growth in earnings before interest, taxes, depreciation, and amortization.

Consolidated Results Demonstrate Strong Performance

The consolidated financial results, which include the company and its subsidiaries, demonstrated robust performance metrics with significant year-over-year improvements. For Q3 FY26, consolidated revenue reached ₹245.00 crores compared to ₹144.00 crores in the corresponding quarter of the previous year, representing substantial growth in business operations.

Parameter: Q3 FY26 Q3 FY25 Change (%) Consolidated Revenue: ₹245.00 crores ₹144.00 crores +70.14% Consolidated Net Profit: ₹36.00 crores ₹34.00 crores +5.88% Consolidated EPS: ₹0.59 Not Available -

The nine-month consolidated results showed revenue from operations of ₹740.06 crores and net profit of ₹161.49 crores, reflecting the company's expanded business operations through its subsidiary structure.

Standalone Financial Performance

The company's standalone results for Q3 FY26 showed mixed performance with revenue growth offset by margin pressure. Revenue from operations reached ₹141.94 crores compared to ₹139.47 crores in the corresponding quarter of the previous year, while net profit stood at ₹31.84 crores versus ₹33.45 crores in Q3 FY25.

Financial Metric: Q3 FY26 Q3 FY25 Change (%) Standalone Revenue: ₹141.94 crores ₹139.47 crores +1.77% Standalone Net Profit: ₹31.84 crores ₹33.45 crores -4.82% Earnings Per Share: ₹0.52 ₹0.55 -5.45%

For the nine-month period ended December 31, 2025, the company achieved stronger year-over-year growth with revenue from operations reaching ₹494.13 crores compared to ₹421.79 crores in the corresponding period of FY25.

IPO Completion and Market Listing

Subsequent to the quarter ended December 31, 2025, the company successfully completed its Initial Public Offering (IPO) of 2,08,86,200 equity shares of face value ₹5 each at an issue price of ₹79 per share. The IPO aggregated to ₹1,650.01 crores including estimated offer expenses, with an offer for sale component of 94,93,700 equity shares amounting to ₹750.00 crores. The company's equity shares were listed on February 27, 2026, marking a significant milestone in its corporate journey.

Financial Position and Business Operations

The company maintains a paid-up equity share capital of ₹306.97 crores with a face value of ₹5 per share. The company operates primarily in the healthcare business segment, focusing on IVF and women's health services as its core business area. Total expenses for the standalone business in Q3 FY26 were ₹99.51 crores, with key components including employee benefits expense of ₹20.69 crores, finance costs of ₹11.23 crores, and advertisement expenses of ₹12.67 crores.

Gaudium IVF & Women Health Limited has announced the appointment of new Internal and Secretarial Auditors for the financial year 2025-2026, following a Board of Directors meeting held on March 18, 2026. The appointments were made based on recommendations from the company's Audit Committee and comply with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The Board of Directors meeting commenced at 4:15 p.m. (IST) and concluded at 06:05 p.m. (IST) on March 18, 2026. The company has formally notified both BSE Limited and National Stock Exchange of India Limited about these appointments as required under Regulation 30 of SEBI regulations.

Internal Auditor Appointment

The board approved the appointment of M/s. Ram Rattan & Associates, Chartered Accountants as Internal Auditors for the financial year 2025-2026. The following table summarizes the key details:

Parameter: Details Firm Name: M/s. Ram Rattan & Associates, Chartered Accountants Appointment Date: March 18, 2026 Term: Financial Year 2025-2026 Establishment Year: 1984 Team Size: Over 15 professionals Locations: Head office in Delhi, branch office in Gurgaon

Ram Rattan & Associates is a New Delhi-based Chartered Accountancy firm led by Founder and Managing Partner, FCA Ram Rattan Gupta. The firm has been peer-reviewed since inception and provides comprehensive services including Lead Advisory, Direct & Indirect Tax Consultancy, Audit & Assurance, Restructuring, Startup Recognition, Financing, Valuation, and Back-Office Support.

Secretarial Auditor Appointment

The company also appointed M/s. Suresh Nainwal & Company, Practicing Company Secretaries as Secretarial Auditors for the financial year 2025-2026 until the date of the ensuing Annual General Meeting.

Parameter: Details Firm Name: M/s. Suresh Nainwal & Company, Practicing Company Secretaries Registration Number: S2020DE7647200 Peer Review Number: 3349/2023 Appointment Date: March 18, 2026 Term: Financial Year 2025-2026 till AGM Experience: Over 6 years Location: New Delhi

Firm Expertise and Services

Suresh Nainwal & Company is a proprietorship and peer-reviewed firm with over 6 years of experience in delivering legal and secretarial services to leading corporates. The proprietor, Mr. Suresh Chandra Nainwal, is also a Designated Partner of SGS Associates LLP, Practicing Company Secretaries.

The firm's expertise includes:

Board management and compliance management

Committee management and secretarial department management

Companies Act and SEBI guidelines compliance

Issue of Bonus Shares, Right Issue, Private Placement

Annual General Meeting management

Mergers and acquisitions

Liaison with Registrar and Share Transfer Agents, Depositories & Stock Exchanges

Regulatory Compliance

Both appointments have been made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically under Regulation 30. The company has provided detailed annexures with complete information about both appointments as required by the regulations. The information will also be uploaded on the company's website for public access.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.